File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1097/01.ASN.0000070071.57901.B3
- Scopus: eid_2-s2.0-0038205906
- PMID: 12819248
- WOS: WOS:000183813300019
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?
Title | Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? |
---|---|
Authors | |
Issue Date | 2003 |
Publisher | American Society of Nephrology. The Journal's web site is located at http://www.jasn.org |
Citation | Journal Of The American Society Of Nephrology, 2003, v. 14 n. 7, p. 1871-1879 How to Cite? |
Abstract | C-reactive protein is the prototype marker of inflammation and has been shown to predict mortality in hemodialysis patients. However, it remains uncertain as to whether a single C-reactive protein level has similar prognostic significance in peritoneal dialysis patients. A single high-sensitivity C-reactive protein (hs-CRP) level was measured in 246 continuous ambulatory peritoneal dialysis patients without active infections at study baseline together with indices of dialysis adequacy, echocardiographic parameters (left ventricular mass index, left ventricular dimensions, and ejection fraction), nutrition markers (serum albumin, dietary intake, and subjective global assessment) and biochemical parameters (hemoglobin, lipids, calcium, and phosphate). The cohort was then followed-up prospectively for a median of 24 mo (range, 2 to 34 mo), and outcomes were studied in relation to these parameters. Fifty-nine patients died (36 from cardiovascular causes) during the follow-up period. The median hs-CRP level was 2.84 mg/L (range, 0.20 to 94.24 mg/L). Patients were stratified into tertiles according to baseline hs-CRP, namely those with hs-CRP ≤ 1.26 mg/L, 1.27 to 5.54 mg/L, and ≥ 5.55 mg/L. Those with higher hs-CRP were significantly older (P < 0.001), had greater body mass index (P < 0.001), higher prevalence of coronary artery disease (P = 0.003), and greater left ventricular mass index (P < 0.001). One-year overall mortality was 3.9% (lower) versus 8.8% (middle) versus 21.3% (upper tertile) (P < 0.0001). Cardiovascular death rate was 2.7% (lower) versus 5.2% (middle) versus 16.2% (upper tertile) (P < 0.0001). Multivariable Cox regression analysis showed that every 1 mg/L increase in hs-CRP was independently predictive of higher all-cause mortality (hazard ratio [HR], 1.02; 95% CI, 1.01 to 1.04; P = 0.002) and cardiovascular mortality (HR, 1.03; 95% CI, 1.01 to 1.05; P = 0.001) in peritoneal dialysis patients. Other significant predictors for all-cause mortality included age (HR, 1.07; 95% CI, 1.04 to 1.10), gender (HR, 0.49; 95% CI, 0.27 to 0.90), atherosclerotic vascular disease (HR, 2.65; 95% CI, 1.46 to 4.80), left ventricular mass index (HR, 1.01; 95% CI, 1.00 to 1.01) and residual GFR (HR, 0.53; 95% CI, 0.38 to 0.75). Age (HR, 1.06; 95% CI, 1.02 to 1.10), history of heart failure (HR, 3.31; 95% CI, 1.36 to 8.08), atherosclerotic vascular disease (HR, 3.20; 95% CI, 1.43 to 7.13), and residual GFR (HR, 0.57; 95% CI, 0.38 to 0.86) were also independently predictive of cardiovascular mortality. In conclusion, a single, random hs-CRP level has significant and independent prognostic value in PD patients. |
Persistent Identifier | http://hdl.handle.net/10722/162697 |
ISSN | 2023 Impact Factor: 10.3 2023 SCImago Journal Rankings: 3.409 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wang, AYM | en_US |
dc.contributor.author | Woo, J | en_US |
dc.contributor.author | Lam, CWK | en_US |
dc.contributor.author | Wang, M | en_US |
dc.contributor.author | Sea, MMM | en_US |
dc.contributor.author | Lui, SF | en_US |
dc.contributor.author | Li, PKT | en_US |
dc.contributor.author | Sanderson, J | en_US |
dc.date.accessioned | 2012-09-05T05:22:26Z | - |
dc.date.available | 2012-09-05T05:22:26Z | - |
dc.date.issued | 2003 | en_US |
dc.identifier.citation | Journal Of The American Society Of Nephrology, 2003, v. 14 n. 7, p. 1871-1879 | en_US |
dc.identifier.issn | 1046-6673 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/162697 | - |
dc.description.abstract | C-reactive protein is the prototype marker of inflammation and has been shown to predict mortality in hemodialysis patients. However, it remains uncertain as to whether a single C-reactive protein level has similar prognostic significance in peritoneal dialysis patients. A single high-sensitivity C-reactive protein (hs-CRP) level was measured in 246 continuous ambulatory peritoneal dialysis patients without active infections at study baseline together with indices of dialysis adequacy, echocardiographic parameters (left ventricular mass index, left ventricular dimensions, and ejection fraction), nutrition markers (serum albumin, dietary intake, and subjective global assessment) and biochemical parameters (hemoglobin, lipids, calcium, and phosphate). The cohort was then followed-up prospectively for a median of 24 mo (range, 2 to 34 mo), and outcomes were studied in relation to these parameters. Fifty-nine patients died (36 from cardiovascular causes) during the follow-up period. The median hs-CRP level was 2.84 mg/L (range, 0.20 to 94.24 mg/L). Patients were stratified into tertiles according to baseline hs-CRP, namely those with hs-CRP ≤ 1.26 mg/L, 1.27 to 5.54 mg/L, and ≥ 5.55 mg/L. Those with higher hs-CRP were significantly older (P < 0.001), had greater body mass index (P < 0.001), higher prevalence of coronary artery disease (P = 0.003), and greater left ventricular mass index (P < 0.001). One-year overall mortality was 3.9% (lower) versus 8.8% (middle) versus 21.3% (upper tertile) (P < 0.0001). Cardiovascular death rate was 2.7% (lower) versus 5.2% (middle) versus 16.2% (upper tertile) (P < 0.0001). Multivariable Cox regression analysis showed that every 1 mg/L increase in hs-CRP was independently predictive of higher all-cause mortality (hazard ratio [HR], 1.02; 95% CI, 1.01 to 1.04; P = 0.002) and cardiovascular mortality (HR, 1.03; 95% CI, 1.01 to 1.05; P = 0.001) in peritoneal dialysis patients. Other significant predictors for all-cause mortality included age (HR, 1.07; 95% CI, 1.04 to 1.10), gender (HR, 0.49; 95% CI, 0.27 to 0.90), atherosclerotic vascular disease (HR, 2.65; 95% CI, 1.46 to 4.80), left ventricular mass index (HR, 1.01; 95% CI, 1.00 to 1.01) and residual GFR (HR, 0.53; 95% CI, 0.38 to 0.75). Age (HR, 1.06; 95% CI, 1.02 to 1.10), history of heart failure (HR, 3.31; 95% CI, 1.36 to 8.08), atherosclerotic vascular disease (HR, 3.20; 95% CI, 1.43 to 7.13), and residual GFR (HR, 0.57; 95% CI, 0.38 to 0.86) were also independently predictive of cardiovascular mortality. In conclusion, a single, random hs-CRP level has significant and independent prognostic value in PD patients. | en_US |
dc.language | eng | en_US |
dc.publisher | American Society of Nephrology. The Journal's web site is located at http://www.jasn.org | en_US |
dc.relation.ispartof | Journal of the American Society of Nephrology | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Age Factors | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Body Mass Index | en_US |
dc.subject.mesh | C-Reactive Protein - Biosynthesis | en_US |
dc.subject.mesh | Cohort Studies | en_US |
dc.subject.mesh | Echocardiography | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Peritoneal Dialysis | en_US |
dc.subject.mesh | Prognosis | en_US |
dc.subject.mesh | Proportional Hazards Models | en_US |
dc.subject.mesh | Prospective Studies | en_US |
dc.subject.mesh | Time Factors | en_US |
dc.subject.mesh | Treatment Outcome | en_US |
dc.title | Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? | en_US |
dc.type | Article | en_US |
dc.identifier.email | Wang, M:meiwang@hkucc.hku.hk | en_US |
dc.identifier.authority | Wang, M=rp00281 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1097/01.ASN.0000070071.57901.B3 | en_US |
dc.identifier.pmid | 12819248 | - |
dc.identifier.scopus | eid_2-s2.0-0038205906 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0038205906&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 14 | en_US |
dc.identifier.issue | 7 | en_US |
dc.identifier.spage | 1871 | en_US |
dc.identifier.epage | 1879 | en_US |
dc.identifier.isi | WOS:000183813300019 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Wang, AYM=13606226000 | en_US |
dc.identifier.scopusauthorid | Woo, J=36040369400 | en_US |
dc.identifier.scopusauthorid | Lam, CWK=8531362100 | en_US |
dc.identifier.scopusauthorid | Wang, M=7406690398 | en_US |
dc.identifier.scopusauthorid | Sea, MMM=6602566931 | en_US |
dc.identifier.scopusauthorid | Lui, SF=7102379144 | en_US |
dc.identifier.scopusauthorid | Li, PKT=25928016800 | en_US |
dc.identifier.scopusauthorid | Sanderson, J=7202371250 | en_US |
dc.identifier.issnl | 1046-6673 | - |